{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-316067","form_type":"8-K","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2026-07-24T20:05:14+00:00","discovered_at":"2026-07-24T20:06:00.405185+00:00","generated_at":"2026-07-24T20:06:12.514900+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"FibroBiologics receives Nasdaq delisting notice for bid price non-compliance","bullets":["Nasdaq Staff Determination on July 22, 2026: bid price below $1.00 for 30 consecutive business days (June 8–July 21, 2026).","Company ineligible for 180-day cure period due to reverse stock split within prior year (Listing Rule 5810(c)(3)(A)(iv)).","Delisting scheduled for July 31, 2026 unless appeal requested by July 29, 2026; company intends to request hearing.","At hearing, company will present plan to regain compliance; no assurance of success."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-316067","json":"https://secwatch.observer/filing/0001193125-26-316067.json","markdown":"https://secwatch.observer/filing/0001193125-26-316067.md","text":"https://secwatch.observer/filing/0001193125-26-316067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526316067/0001193125-26-316067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000119312526316067/fblg-20260722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-24T20:06:12.514900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}